Lista de obras -

Analytical Advances in the Ex Vivo Challenge Efficacy Assay

artículo científico publicado en 2016

Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study

scientific article published on 17 September 2020

Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis

artículo científico publicado en 2016

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype

scientific article published on 25 June 2019

Candidate microbicides and their mechanisms of action

artículo científico

Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants

artículo científico publicado en 2011

Colorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytes

artículo científico publicado en 2015

Combinations of Entry and Reverse Transcriptase Inhibitors as Candidate Microbicides

artículo científico publicado en 2014

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial

artículo científico publicado en 2020

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs

artículo científico publicado en 2021

Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo

scientific article published on 01 October 2020

Evaluation of Mucosal Tissue Explants as Ex Vivo Surrogates of In Vivo Vaccination of Non-human Primates (NHPs) and Humans

artículo científico publicado en 2014

Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human Primates

artículo científico publicado en 2022

Exploring Innovative Approaches to the Formulation of Microbicides to Boost Antiretroviral Drug Delivery and Activity at Mucosal Sites

artículo científico publicado en 2014

HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights

artículo científico publicado en 2019

HIV-1 CNS in vitro infectivity models based on clinical CSF samples

artículo científico publicado en 2015

HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells

artículo científico publicado en 2022

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

artículo científico publicado en 2016

Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide

artículo científico publicado en 2020

Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates.

artículo científico publicado en 2016

Measurements of immune responses for establishing correlates of vaccine protection against HIV

artículo científico publicado en 2012

MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques

artículo científico publicado en 2012

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa

artículo científico publicado en 2022

Mucosal Responses to Zika Virus Infection in Cynomolgus Macaques

artículo científico publicado en 2022

Mucosal Tissue Explants as Surrogates for In Vivo Efficacy of Microbicides

artículo científico publicado en 2014

Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones

artículo científico publicado en 2018

Neutralization sensitivity of HIV-1 Env-pseudotyped virus clones is determined by co-operativity between mutations which modulate the CD4-binding site and those that affect gp120-gp41 stability.

artículo científico publicado en 2005

Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site

artículo científico publicado en 2003

Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo

artículo científico publicado en 2017

Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control

artículo científico publicado en 2021

P251 The induction of early, dynamic airway mucosal and systemic immune responses following recent SARS-CoV-2 household exposure

artículo científico publicado en 2021

Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity

artículo científico publicado en 2021

Pharmaceutical Approaches to HIV Treatment and Prevention

scientific article published on 29 July 2018

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)

artículo científico publicado en 2021

Potential use of protease inhibitors as vaginal and colorectal microbicides

artículo científico publicado en 2012

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue

artículo científico publicado en 2022

Preclinical Evaluation of Multi-targeting Antiretroviral Drug Based-combinations as Candidate Microbicides

artículo científico publicado en 2014

Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide

artículo científico publicado en 2012

Preliminary Evaluation of Serpins as Potential Candidate Microbicides

artículo científico publicado en 2014

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel

artículo científico publicado en 2008

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen

artículo científico publicado en 2023

Reverse transcriptase inhibitors as potential colorectal microbicides

scientific article published on 02 March 2009

Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention

artículo científico publicado en 2012

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

artículo científico publicado en 2015

Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks

artículo científico publicado en 2017

Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention

artículo científico publicado en 2019

The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models.

artículo científico publicado en 2019

The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate

artículo científico publicado en 2021

The pharmacology of HIV-1 antiretrovirals differs between macaques and humans

artículo científico publicado en 2022

Lista de obras de

Analytical Advances in the Ex Vivo Challenge Efficacy Assay

Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study

Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype

Candidate microbicides and their mechanisms of action

Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants

Colorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytes

Combinations of Entry and Reverse Transcriptase Inhibitors as Candidate Microbicides

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs

Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo

Evaluation of Mucosal Tissue Explants as Ex Vivo Surrogates of In Vivo Vaccination of Non-human Primates (NHPs) and Humans

Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human Primates

Exploring Innovative Approaches to the Formulation of Microbicides to Boost Antiretroviral Drug Delivery and Activity at Mucosal Sites

HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights

HIV-1 CNS in vitro infectivity models based on clinical CSF samples

HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide

Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates.

Measurements of immune responses for establishing correlates of vaccine protection against HIV

MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa

Mucosal Responses to Zika Virus Infection in Cynomolgus Macaques

Mucosal Tissue Explants as Surrogates for In Vivo Efficacy of Microbicides

Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones

Neutralization sensitivity of HIV-1 Env-pseudotyped virus clones is determined by co-operativity between mutations which modulate the CD4-binding site and those that affect gp120-gp41 stability.

Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site

Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo

Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control

P251 The induction of early, dynamic airway mucosal and systemic immune responses following recent SARS-CoV-2 household exposure

Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity

Pharmaceutical Approaches to HIV Treatment and Prevention

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)

Potential use of protease inhibitors as vaginal and colorectal microbicides

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue

Preclinical Evaluation of Multi-targeting Antiretroviral Drug Based-combinations as Candidate Microbicides

Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide

Preliminary Evaluation of Serpins as Potential Candidate Microbicides

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen

Reverse transcriptase inhibitors as potential colorectal microbicides

Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks

Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention

The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models.

The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate

The pharmacology of HIV-1 antiretrovirals differs between macaques and humans